Cargando…
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanide...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398612/ https://www.ncbi.nlm.nih.gov/pubmed/34451903 http://dx.doi.org/10.3390/ph14080806 |
_version_ | 1783744881443733504 |
---|---|
author | Blahova, Jana Martiniakova, Monika Babikova, Martina Kovacova, Veronika Mondockova, Vladimira Omelka, Radoslav |
author_facet | Blahova, Jana Martiniakova, Monika Babikova, Martina Kovacova, Veronika Mondockova, Vladimira Omelka, Radoslav |
author_sort | Blahova, Jana |
collection | PubMed |
description | Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium–glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided. |
format | Online Article Text |
id | pubmed-8398612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83986122021-08-29 Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus Blahova, Jana Martiniakova, Monika Babikova, Martina Kovacova, Veronika Mondockova, Vladimira Omelka, Radoslav Pharmaceuticals (Basel) Review Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium–glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided. MDPI 2021-08-17 /pmc/articles/PMC8398612/ /pubmed/34451903 http://dx.doi.org/10.3390/ph14080806 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Blahova, Jana Martiniakova, Monika Babikova, Martina Kovacova, Veronika Mondockova, Vladimira Omelka, Radoslav Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title_full | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title_fullStr | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title_full_unstemmed | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title_short | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus |
title_sort | pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398612/ https://www.ncbi.nlm.nih.gov/pubmed/34451903 http://dx.doi.org/10.3390/ph14080806 |
work_keys_str_mv | AT blahovajana pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus AT martiniakovamonika pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus AT babikovamartina pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus AT kovacovaveronika pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus AT mondockovavladimira pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus AT omelkaradoslav pharmaceuticaldrugsandnaturaltherapeuticproductsforthetreatmentoftype2diabetesmellitus |